Oxaliplatin-Teva liquid 200 mg/40 ml, Konzentrat zur Herstellung einer Infusionslösung

7680616880031 CH-61688 Konzentrat
Oxaliplatin-Teva liquid 200 mg/40 ml, Konzentrat zur Herstellung einer Infusionslösung
Oxaliplatin-Teva liquid 200 mg/40 ml, Konzentrat zur Herstellung einer Infusionslösung
Oxaliplatin-Teva liquid 200 mg/40 ml, Konzentrat zur Herstellung einer Infusionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Konzentrat
Galenic group
Tinkturen/Desinfektion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
16/08/2023
Summary of Product Characteristics
Français
16/08/2023
Summary of Product Characteristics
Italien
16/08/2023

Detailed composition

Substance Quantity Type Category
(N/A)
200.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 302.15
Specialties list
Yes
Generic
Yes
SL addition date: 01/04/2020

Authorization holder

Teva Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
61688
Drug name
Oxaliplatin-Teva liquid, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
L01XA03
Authorization status
Z
Dispensing category
A
First authorization
04/03/2011
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
Zytostatikum

Package details

Description (FR)
OXALIPLATIN Teva liquid 200 mg/40ml flac 40 ml
Description (DE)
OXALIPLATIN Teva liquid 200 mg/40ml Durchstf 40 ml
Market launch
04/03/2011
Narcotic (BTM)
No

Other package sizes (2)

OXALIPLATIN Teva liquid 50 mg/10ml flac 10 ml
1 DUR
GTIN: 7680616880017
View
OXALIPLATIN Teva liquid 100 mg/20ml flac 20 ml
1 DUR
GTIN: 7680616880024
View